{
  "actions": [
    {
      "acted_at": "2000-09-25", 
      "references": [
        {
          "reference": "CR S9199", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "2000-09-25", 
      "committee": "Committee on Finance", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Finance.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s3103-106", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Finance", 
      "committee_id": "SSFI"
    }
  ], 
  "congress": "106", 
  "cosponsors": [
    {
      "district": null, 
      "name": "Bryan, Richard H.", 
      "sponsored_at": "2000-09-25", 
      "state": "NV", 
      "thomas_id": "01293", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2000-09-25", 
  "number": "3103", 
  "official_title": "A bill to amend the Internal Revenue Code of 1986 to impose a discriminatory profits tax on pharmaceutical companies which charge prices for prescription drugs to domestic wholesale distributors that exceed the most favored customer prices charged to foreign wholesale distributors.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": null, 
  "sponsor": {
    "district": null, 
    "name": "Levin, Carl", 
    "state": "MI", 
    "thomas_id": "01384", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2000-09-25", 
  "subjects": [
    "Canada", 
    "Commerce", 
    "Crime and law enforcement", 
    "Drug industry", 
    "Drugs", 
    "Economics and public finance", 
    "Europe", 
    "European Union", 
    "Excess profits tax", 
    "Excise tax", 
    "Exports", 
    "Foreign trade and international finance", 
    "Government trust funds", 
    "Health", 
    "Medicare", 
    "Perjury", 
    "Prescription pricing", 
    "Social welfare", 
    "Tax returns", 
    "Taxation", 
    "Wholesale trade"
  ], 
  "subjects_top_term": "Taxation", 
  "summary": {
    "as": "Introduced", 
    "date": "2000-09-25", 
    "text": "Amends the Internal Revenue Code to impose a tax equal to ten percent of the taxable income of a taxpayer who: (1) has any gross income attributable to the manufacture or production of prescription drugs; and (2) fails to include with its tax return a signed statement declaring that it is the taxpayer's policy not to directly or indirectly charge any U.S. wholesale distributor a higher unit price for any bulk purchase of a prescription drug than the most favored customer price it directly or indirectly charges any wholesale distributor located in any covered foreign country for any bulk purchase of such drug."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "A bill to amend the Internal Revenue Code of 1986 to impose a discriminatory profits tax on pharmaceutical companies which charge prices for prescription drugs to domestic wholesale distributors that exceed the most favored customer prices charged to foreign wholesale distributors.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:42:28-05:00"
}